We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

272210:KRXHanwha Systems Co., Ltd. Analysis

Data as of 2026-05-27 - not real-time

₩110,700.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Hanwha Systems is posting solid top‑line growth driven by expanding defense and aerospace contracts, yet its margins remain thin and cash conversion is weak, leading to a negative free‑cash‑flow profile. The forward price‑to‑earnings multiple sits well above the industry average, suggesting the stock is priced for strong future earnings that may be difficult to deliver. Dividend yield is modest and the payout ratio approaches the upper half of earnings, raising questions about dividend sustainability. High leverage further strains the balance sheet, with debt levels far exceeding equity. Technical analysis shows the price hovering near a well‑established support zone while the 20‑day and 50‑day moving averages remain above the current price, indicating limited upside momentum. RSI sits in a neutral band and the MACD histogram has turned modestly positive, offering a slight bullish bias but not enough to offset the broader valuation concerns. Volume trends are declining, reflecting waning market participation. Volatility is elevated, and beta indicates sensitivity to broader market swings, amplifying risk in uncertain environments. The sector benefits from steady government spending, yet regulatory and geopolitical factors add layers of uncertainty. Overall, the stock appears overvalued relative to its earnings outlook and cash‑flow generation, warranting a cautious stance.
Investors should weigh the strong revenue trajectory against the high debt load, thin profitability, and elevated valuation before committing capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near established support level
  • neutral technical momentum
  • declining trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • robust revenue growth
  • high forward valuation multiple
  • significant debt burden

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • overvalued pricing relative to earnings and cash flow
  • persistent negative free cash flow
  • elevated leverage and volatility

Key Metrics & Analysis

Financial Health

Revenue Growth17.00%
Profit Margin4.22%
P/E Ratio48.5
ROE2.24%
ROA0.83%
Debt/Equity39.35
Op. Cash Flow₩33.4B
Free Cash Flow₩-325492473856
Industry P/E30.1

Technical Analysis

TrendNeutral
RSI45.1
Support₩99,700.00
Resistance₩130,900.00
MA 20₩113,220.00
MA 50₩124,094.00
MA 200₩83,094.75
MACDBullish
VolumeDecreasing
Fear & Greed Index91.05

Valuation

Target Price₩105,541.66
Upside/Downside-4.66%
GradeOvervalued
TypeGrowth
Dividend Yield0.43%

Risk Assessment

Beta1.29
Volatility53.52%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.